Expert Interview
Discussing the implications of recent changes to the Advisory Committee on Immunization Practices (ACIP) and its impacts on vaccine makers, their strategies, and vaccine availability.
Ticker(s): MRNA, NVAXInstitution: Self Employed
-
Quality Assurance Executive with over 25 years leading global compliance in cell and gene therapy, biopharmaceuticals, small molecules, medical devices, and combination products.
-
Drives innovation using data analytics and IT, overseeing audits, regulatory inspections, process design, technology transfer, and new product launches.
-
Manages FDA, EMA, and MHRA compliance, including GMP, GLP, GCP audits, deviation investigations, CAPA, and validation for equipment, processes, and facilities.
Do you want answers to these questions?
Slingshot Insights Explained
- Call Date
- Jun 20, 2025
- Call Time
- 11:00 AM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
